BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Amsterdam Molecular Therapeutics (AMT) 

Meibergdreef 61

Amsterdam    1100 DA  The Netherlands
Phone: 31-0-20-5667394 Fax: 31-0-20-5667585


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting 7/16/2012 10:04:24 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Receives Further Opinion on Glybera® Marketing Authorization Application 4/23/2012 7:04:47 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Announces Completion of Disposal of its Operations to uniQure B.V. and its Dissolution Becoming Effective 4/6/2012 10:01:17 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Announces Results of Extraordinary General Meeting 4/2/2012 10:27:37 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Publishes Positive Data from Glybera® 14 Week Study 3/28/2012 7:21:04 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Receives Request for Further Information From CHMP on Glybera(R) 2/21/2012 10:10:24 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Announces European Commission (EC) Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP 1/30/2012 7:05:45 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Receives US Orphan Designation for Hemophilia B Gene Therapy 1/4/2012 9:59:37 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Announces € 2.5 Million Equity Raise 1/3/2012 9:05:31 AM    More...
Amsterdam Molecular Therapeutics (AMT) (RHP.DE) Announces Negative Equity Position 12/15/2011 10:42:30 AM    More...
1234567

//-->